LLC PHARMACOR PRODUCTION · 99-39 · RUSSIA
For LLC PHARMACOR PRODUCTION, import alert is 99-39; country is RUSSIA; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; product is DIETARY SUPPLEMENT VLADONIX | DIETARY SUPPLEMENT VLADONIX; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 02/23/2024; address is K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA, verified against its source on 2026-09-30.
- Firm
- LLC PHARMACOR PRODUCTION verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- RUSSIA verified
- Address
- K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA verified
- Date published
- 02/23/2024 verified
- Product code
- 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
- Product
- DIETARY SUPPLEMENT VLADONIX | DIETARY SUPPLEMENT VLADONIX each item verified
- FDA notes
- The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). | The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). each item verified
What the source says
LLC PHARMACOR PRODUCTION Date Published : 02/23/2024 K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 02/23/2024 Desc: DIETARY SUPPLEMENT VLADONIX Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 02/23/2024 Desc: DIETARY SUPPLEMENT VLADONIX Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e).
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html